ArticlePloS one2013
The ranking probability approach and its usage in design and analysis of large-scale studies.
Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
2 authors.
Funding
Abstract
In experiments with many statistical tests there is need to balance type I and type II error rates while taking multiplicity into account. In the traditional approach, the nominal [Formula: see text]-level such as 0.05 is adjusted by the number of tests, [Formula: see text], i.e., as 0.05/[Formula: see text]. Assuming that some proportion of tests represent "true signals", that is, originate from a scenario where the null hypothesis is false, power depends on the number of true signals and the respective distribution of effect sizes. One way to define power is for it to be the probability of making at least one correct rejection at the assumed [Formula: see text]-level. We advocate an alternative way of establishing how "well-powered" a study is. In our approach, useful for studies with multiple tests, the ranking probability [Formula: see text] is controlled, defined as the probability of making at least [Formula: see text] correct rejections while rejecting hypotheses with [Formula: see text] smallest P-values. The two approaches are statistically related. Probability that the smallest P-value is a true signal (i.e., [Formula: see text]) is equal to the power at the level [Formula: see text], to an very good excellent approximation. Ranking probabilities are also related to the false discovery rate and to the Bayesian posterior probability of the null hypothesis. We study properties of our approach when the effect size distribution is replaced for convenience by a single "typical" value taken to be the mean of the underlying distribution. We conclude that its performance is often satisfactory under this simplification; however, substantial imprecision is to be expected when [Formula: see text] is very large and [Formula: see text] is small. Precision is largely restored when three values with the respective abundances are used instead of a single typical effect size value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.